Liquidia Corp. (LQDA)
68.15
+0.46
(+0.68%)
USD |
NASDAQ |
Aug 31, 16:00
68.26
+0.11
(+0.16%)
After-Hours: 20:00
Liquidia Cash from Operations (TTM) : 167.71M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 167.71M |
| March 31, 2026 | 47.98M |
| December 31, 2025 | -35.69M |
| September 30, 2025 | -100.74M |
| June 30, 2025 | -116.06M |
| March 31, 2025 | -99.24M |
| December 31, 2024 | -93.42M |
| September 30, 2024 | -88.59M |
| June 30, 2024 | -75.07M |
| March 31, 2024 | -57.97M |
| December 31, 2023 | -41.56M |
| September 30, 2023 | -30.18M |
| June 30, 2023 | -24.40M |
| March 31, 2023 | -27.26M |
| December 31, 2022 | -28.59M |
| September 30, 2022 | -31.54M |
| June 30, 2022 | -31.60M |
| March 31, 2022 | -31.43M |
| Date | Value |
|---|---|
| December 31, 2021 | -34.04M |
| September 30, 2021 | -40.56M |
| June 30, 2021 | -47.24M |
| March 31, 2021 | -52.09M |
| December 31, 2020 | -54.14M |
| September 30, 2020 | -54.12M |
| June 30, 2020 | -53.56M |
| March 31, 2020 | -52.61M |
| December 31, 2019 | -48.28M |
| September 30, 2019 | -42.55M |
| June 30, 2019 | -36.88M |
| March 31, 2019 | -31.94M |
| December 31, 2018 | -31.83M |
| September 30, 2018 | -28.16M |
| June 30, 2018 | -27.14M |
| March 31, 2018 | -25.25M |
| December 31, 2017 | -24.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Indivior Pharmaceuticals, Inc. | -48.64M |
| Harmony Biosciences Holdings, Inc. | 355.08M |
| Johnson & Johnson | 27.61B |
| United Therapeutics Corp. | 1.682B |
| Amneal Pharmaceuticals, Inc. | 198.80M |